269 related articles for article (PubMed ID: 8622876)
21. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
[TBL] [Abstract][Full Text] [Related]
22. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
[TBL] [Abstract][Full Text] [Related]
23. Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR.
Sartelet H; Grossi L; Pasquier D; Combaret V; Bouvier R; Ranchère D; Plantaz D; Munzer M; Philip T; Birembaut P; Zahm JM; Bergeron C; Gaillard D; Pasquier B
J Pathol; 2002 Sep; 198(1):83-91. PubMed ID: 12210067
[TBL] [Abstract][Full Text] [Related]
24. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.
Manohar CF; Salwen HR; Brodeur GM; Cohn SL
Genes Chromosomes Cancer; 1995 Nov; 14(3):196-203. PubMed ID: 8589036
[TBL] [Abstract][Full Text] [Related]
25. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
26. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K
Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
[TBL] [Abstract][Full Text] [Related]
27. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.
Weber A; Imisch P; Bergmann E; Christiansen H
J Clin Oncol; 2004 Jul; 22(13):2681-90. PubMed ID: 15226335
[TBL] [Abstract][Full Text] [Related]
28. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines.
Akiyama K; Akao Y; Yokoyama M; Nakagawa Y; Noguchi T; Yagi K; Nishi Y
Biochem Mol Biol Int; 1999 Apr; 47(4):563-8. PubMed ID: 10319407
[TBL] [Abstract][Full Text] [Related]
29. Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group.
Christiansen H; Delattre O; Fuchs S; Theobald M; Christiansen NM; Berthold F; Lampert F
Prog Clin Biol Res; 1994; 385():19-25. PubMed ID: 7972212
[TBL] [Abstract][Full Text] [Related]
30. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
[TBL] [Abstract][Full Text] [Related]
31. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region.
Hiyama E; Hiyama K; Yokoyama T
Cancer Res; 1991 Apr; 51(7):1946-51. PubMed ID: 2004381
[TBL] [Abstract][Full Text] [Related]
32. High-resolution mapping of the N-myc amplicon core domain in neuroblastomas.
Hiemstra JL; Schneider SS; Brodeur GM
Prog Clin Biol Res; 1994; 385():51-7. PubMed ID: 7972237
[TBL] [Abstract][Full Text] [Related]
33. MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.
Spitz R; Hero B; Skowron M; Ernestus K; Berthold F
Eur J Cancer; 2004 Dec; 40(18):2753-9. PubMed ID: 15571958
[TBL] [Abstract][Full Text] [Related]
34. Mapping of the syndecan genes in the mouse: linkage with members of the myc gene family.
Spring J; Goldberger OA; Jenkins NA; Gilbert DJ; Copeland NG; Bernfield M
Genomics; 1994 Jun; 21(3):597-601. PubMed ID: 7959737
[TBL] [Abstract][Full Text] [Related]
35. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
[TBL] [Abstract][Full Text] [Related]
36. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
[TBL] [Abstract][Full Text] [Related]
37. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
38. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma.
Wimmer K; Zhu XX; Lamb BJ; Kuick R; Ambros P; Kovar H; Thoraval D; Elkahloun A; Meltzer P; Hanash SM
Med Pediatr Oncol; 2001 Jan; 36(1):75-9. PubMed ID: 11464910
[TBL] [Abstract][Full Text] [Related]
39. Amplification of N-myc as a prognostic marker for patients with neuroblastoma.
Schwab M
Semin Cancer Biol; 1993 Feb; 4(1):13-8. PubMed ID: 8448374
[TBL] [Abstract][Full Text] [Related]
40. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
Cheng JM; Hiemstra JL; Schneider SS; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Nat Genet; 1993 Jun; 4(2):191-4. PubMed ID: 8102299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
